Sisram Medical Ltd (HKG:1696)
Hong Kong
· Delayed Price · Currency is HKD 3.000
-0.020 (-0.66%)
Apr 29, 2026, 4:08 PM HKT
Sisram Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 365.35 | 349.11 | 359.29 | 354.48 | 294.29 | Upgrade
|
| Revenue Growth (YoY) | 4.65% | -2.83% | 1.36% | 20.45% | 81.56% | Upgrade
|
| Cost of Revenue | 150.2 | 132.43 | 139.77 | 152.25 | 127.43 | Upgrade
|
| Gross Profit | 215.14 | 216.68 | 219.53 | 202.23 | 166.86 | Upgrade
|
| Selling, General & Admin | 165.73 | 165.09 | 159.44 | 128.76 | 100.71 | Upgrade
|
| Research & Development | 16.86 | 15.94 | 18.03 | 18.02 | 15.59 | Upgrade
|
| Other Operating Expenses | 5.53 | 7.98 | 4.03 | 10.04 | 7.8 | Upgrade
|
| Operating Expenses | 188.12 | 189 | 181.5 | 156.82 | 124.1 | Upgrade
|
| Operating Income | 27.03 | 27.68 | 38.03 | 45.41 | 42.76 | Upgrade
|
| Interest Expense | -3.25 | -2.46 | -2.06 | -1.74 | -2.01 | Upgrade
|
| Interest & Investment Income | 0.96 | 1.32 | 0.6 | 0.61 | 0.54 | Upgrade
|
| Earnings From Equity Investments | 0.21 | 0.03 | -0.42 | -0.52 | -0.31 | Upgrade
|
| Currency Exchange Gain (Loss) | 2.51 | - | - | - | 0.49 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.08 | 1.82 | 0.99 | 0.48 | 0.19 | Upgrade
|
| EBT Excluding Unusual Items | 28.55 | 28.39 | 37.13 | 44.24 | 41.67 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 4.15 | - | - | - | Upgrade
|
| Pretax Income | 28.55 | 32.54 | 37.13 | 44.24 | 41.67 | Upgrade
|
| Income Tax Expense | 3.55 | 3.78 | 4.23 | 4.16 | 9.15 | Upgrade
|
| Earnings From Continuing Operations | 25.01 | 28.77 | 32.9 | 40.08 | 32.52 | Upgrade
|
| Minority Interest in Earnings | -5.99 | -3.64 | -1.4 | 0.09 | -1.28 | Upgrade
|
| Net Income | 19.02 | 25.13 | 31.5 | 40.17 | 31.25 | Upgrade
|
| Net Income to Common | 19.02 | 25.13 | 31.5 | 40.17 | 31.25 | Upgrade
|
| Net Income Growth | -24.32% | -20.23% | -21.59% | 28.57% | 134.15% | Upgrade
|
| Shares Outstanding (Basic) | 468 | 468 | 467 | 466 | 453 | Upgrade
|
| Shares Outstanding (Diluted) | 468 | 468 | 468 | 467 | 453 | Upgrade
|
| Shares Change (YoY) | - | - | 0.34% | 3.07% | 2.42% | Upgrade
|
| EPS (Basic) | 0.04 | 0.05 | 0.07 | 0.09 | 0.07 | Upgrade
|
| EPS (Diluted) | 0.04 | 0.05 | 0.07 | 0.09 | 0.07 | Upgrade
|
| EPS Growth | -24.25% | -20.36% | -21.84% | 24.78% | 128.63% | Upgrade
|
| Free Cash Flow | 6.82 | 30.33 | 35.37 | 17.29 | 29.41 | Upgrade
|
| Free Cash Flow Per Share | 0.01 | 0.07 | 0.08 | 0.04 | 0.07 | Upgrade
|
| Dividend Per Share | 0.012 | 0.016 | 0.020 | 0.022 | 0.020 | Upgrade
|
| Dividend Growth | -24.76% | -19.80% | -8.84% | 10.20% | 123.02% | Upgrade
|
| Gross Margin | 58.89% | 62.07% | 61.10% | 57.05% | 56.70% | Upgrade
|
| Operating Margin | 7.40% | 7.93% | 10.58% | 12.81% | 14.53% | Upgrade
|
| Profit Margin | 5.21% | 7.20% | 8.77% | 11.33% | 10.62% | Upgrade
|
| Free Cash Flow Margin | 1.87% | 8.69% | 9.84% | 4.88% | 9.99% | Upgrade
|
| EBITDA | 38.22 | 38.91 | 47.5 | 53.99 | 51.58 | Upgrade
|
| EBITDA Margin | 10.46% | 11.14% | 13.22% | 15.23% | 17.53% | Upgrade
|
| D&A For EBITDA | 11.19 | 11.23 | 9.47 | 8.59 | 8.82 | Upgrade
|
| EBIT | 27.03 | 27.68 | 38.03 | 45.41 | 42.76 | Upgrade
|
| EBIT Margin | 7.40% | 7.93% | 10.58% | 12.81% | 14.53% | Upgrade
|
| Effective Tax Rate | 12.42% | 11.60% | 11.40% | 9.41% | 21.96% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.